Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial von Kaufman, Howard L, Prof, Russell, Jeffery, MD, Hamid, Omid, MD, Bhatia, Shailender, MD, Terheyden, Patrick, MD, D'Angelo, Sandra P, MD, Shih, Kent C, MD, Lebbé, Céleste, Prof, Linette, Gerald P, MD, Milella, Michele, MD, Brownell, Isaac, MD, Lewis, Karl D, MD, Lorch, Jochen H, MD, Chin, Kevin, MD, Mahnke, Lisa, MD, von Heydebreck, Anja, PhD, Cuillerot, Jean-Marie, MD, Nghiem, Paul, Prof

Volltext

Genomic analysis of metastatic cutaneous squamous cell carcinoma von Li, Yvonne Y, Hanna, Glenn J, Laga, Alvaro C, Haddad, Robert I, Lorch, Jochen H, Hammerman, Peter S

Volltext

Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial von Posner, M.R., Lorch, J.H., Goloubeva, O., Tan, M., Schumaker, L.M., Sarlis, N.J., Haddad, R.I., Cullen, K.J.

Volltext

Response and Acquired Resistance to Everolimus in Anaplastic Thyroid Cancer von Wagle, Nikhil, Grabiner, Brian C, Van Allen, Eliezer M, Amin-Mansour, Ali, Taylor-Weiner, Amaro, Rosenberg, Mara, Gray, Nathanael, Barletta, Justine A, Guo, Yanan, Swanson, Scott J, Ruan, Daniel T, Hanna, Glenn J, Haddad, Robert I, Getz, Gad, Kwiatkowski, David J, Carter, Scott L, Sabatini, David M, Jänne, Pasi A, Garraway, Levi A, Lorch, Jochen H

Volltext

Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial von Kaufman, Howard L, Russell, Jeffery S, Hamid, Omid, Bhatia, Shailender, Terheyden, Patrick, D'Angelo, Sandra P, Shih, Kent C, Lebbé, Céleste, Milella, Michele, Brownell, Isaac, Lewis, Karl D, Lorch, Jochen H, von Heydebreck, Anja, Hennessy, Meliessa, Nghiem, Paul

Volltext

Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of th... von Lorch, Jochen H, Dr, Goloubeva, Olga, PhD, Haddad, Robert I, MD, Cullen, Kevin, Prof, Sarlis, Nicholas, MD, Tishler, Roy, MD, Tan, Ming, Prof, Fasciano, John, Sammartino, Daniel E, BSc, Posner, Marshall R, Prof

Volltext

Histological features of BRAF V600E‐mutant anaplastic thyroid carcinoma von Chen, Tiffany Y, Lorch, Jochen H, Wong, Kristine S, Barletta, Justine A

Volltext

Trastuzumab for the Treatment of Salivary Duct Carcinoma von Limaye, Sewanti A., Posner, Marshall R., Krane, Jeffrey F., Fonfria, Maria, Lorch, Jochen H., Dillon, Deborah A., Shreenivas, Aditya V., Tishler, Roy B., Haddad, Robert I.

Volltext

A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma von Hanna, Glenn J., ONeill, Anne, Cutler, Jennifer M., Flynn, Michelle, Vijaykumar, Tushara, Clark, John R., Wirth, Lori J., Lorch, Jochen H., Park, Jong C., Mito, Jeffrey K., Lohr, Jens G., Kaufman, Jeffrey, Burr, Nicole Spardy, Zon, Leonard I., Haddad, Robert I.

Volltext

The Benefits of Adjuvant Trastuzumab for HER‐2‐Positive Salivary Gland Cancers von Hanna, Glenn J., Bae, Ji Eun, Lorch, Jochen H., Haddad, Robert I., Jo, Vickie Y., Schoenfeld, Jonathan D., Margalit, Danielle N., Tishler, Roy B., Goguen, Laura A., Annino, Donald J., Chau, Nicole G.

Volltext

Definitive chemoradiation alters the immunologic landscape and immune checkpoints in head and neck cancer von Sridharan, Vishwajith, Margalit, Danielle N, Lynch, Stephanie A, Severgnini, Mariano, Zhou, Jun, Chau, Nicole G, Rabinowits, Guilherme, Lorch, Jochen H, Hammerman, Peter S, Hodi, F Stephen, Haddad, Robert I, Tishler, Roy B, Schoenfeld, Jonathan D

Volltext

Long-term outcomes and clinicogenomic correlates in recurrent, metastatic adenoid cystic carcinoma von Hanna, Glenn J., Bae, Ji Eun, Lorch, Jochen H., Schoenfeld, Jonathan D., Margalit, Danielle N., Tishler, Roy B., Haddad, Robert I., Chau, Nicole G.

Volltext

Angle-dependent decrease of transition probability in sequential photo double-ionization von Scherer, N, Lörch, H, Kerkau, T, Schmidt, V

Volltext

Induction Chemotherapy for Locoregionally Advanced Head and Neck Cancer: Past, Present, Future? von Hanna, Glenn J., Haddad, Robert I., Lorch, Jochen H.

Volltext

The Safety and Efficacy of Checkpoint Inhibitors in Transplant Recipients: A Case Series and Systematic Review of Literature von Kumar, Vivek, Shinagare, Atul B., Rennke, Helmut G., Ghai, Sandeep, Lorch, Jochen H., Ott, Patrick A., Rahma, Osama E.

Volltext

Influence of post fit and post length on fracture resistance von Büttel, L., Krastl, G., Lorch, H., Naumann, M., Zitzmann, N. U., Weiger, R.

Volltext

Acupuncture for Chemoradiation Therapy‐Related Dysphagia in Head and Neck Cancer: A Pilot Randomized Sham‐Controlled Trial von Lu, Weidong, Wayne, Peter M., Davis, Roger B., Buring, Julie E., Li, Hailun, Macklin, Eric A., Lorch, Jochen H., Burke, Elaine, Haddad, Tyler C., Goguen, Laura A., Rosenthal, David S., Tishler, Roy B., Posner, Marshall R., Haddad, Robert I.

Volltext

Epidermal Growth Factor Receptor Inhibition Promotes Desmosome Assembly and Strengthens Intercellular Adhesion in Squamous Cell Carcinoma Cells von Lorch, Jochen H, Klessner, Jodi, Park, J Ken, Getsios, Spiro, Wu, Yvonne L, Stack, M Sharon, Green, Kathleen J

Volltext

Frameshift events predict anti–PD-1/L1 response in head and neck cancer von Hanna, Glenn J., Lizotte, Patrick, Cavanaugh, Megan, Kuo, Frank C., Shivdasani, Priyanka, Frieden, Alexander, Chau, Nicole G., Schoenfeld, Jonathan D., Lorch, Jochen H., Uppaluri, Ravindra, MacConaill, Laura E., Haddad, Robert I.

Volltext

Autophagic activation potentiates the antiproliferative effects of tyrosine kinase inhibitors in medullary thyroid cancer von Lin, Chi-Iou, PhD, Whang, Edward E., MD, Lorch, Jochen H., MD, Ruan, Daniel T., MD

Volltext